Skip to main content

Armata Pharmaceuticals, Inc.

ARMP
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000921114

No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.

Holders of 5% or more of ARMP

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Armata Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ARMP
HolderLatest formStakeChangeFirst filedLatest filingFiling
Innoviva, Inc.13D/A82.70%55.5M shares−0.40 ppfrom 83.10%Jan 27, 202114 filingsMay 13, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

14 Schedule 13D and 13G filings on Armata Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ARMP
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 13, 20265:21 PM ETInnoviva, Inc.and 1 other13D/A82.70%55.5M shares−0.40 ppfrom 83.10%May 12, 2026SEC
Jan 26, 20264:05 PM ETInnoviva, Inc.and 1 other13D/A83.10%55.5M shares−0.20 ppfrom 83.30%Jan 23, 2026SEC
Aug 12, 20259:38 PM ETInnoviva, Inc.and 1 other13D/A83.30%55.5M shares−1.90 ppfrom 85.20%Aug 11, 2025SEC
Mar 12, 20255:49 PM ETInnoviva, Inc.and 1 other13D/A85.20%64.2M shares–Mar 12, 2025SEC
Nov 14, 2024Innoviva, Inc.13D/AOld format–––SEC
Mar 4, 2024Innoviva, Inc.13D/AOld format–––SEC
Jul 11, 2023Innoviva, Inc.13D/AOld format–––SEC
Jan 10, 2023Innoviva, Inc.13D/AOld format–––SEC
Apr 1, 2022Innoviva, Inc.13D/AOld format–––SEC
Feb 11, 2022Innoviva, Inc.13D/AOld format–––SEC
Nov 1, 2021Innoviva, Inc.13D/AOld format–––SEC
Apr 5, 2021Innoviva, Inc.13D/AOld format–––SEC
Mar 17, 2021Innoviva, Inc.13D/AOld format–––SEC
Jan 27, 2021Innoviva, Inc.13D/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Armata Pharmaceuticals, Inc. shares.

No Form 144 notices for Armata Pharmaceuticals, Inc. are on file.